01 - Header Landing

Agenda

We're still finalizing details for the 2025 conference. Please note that speakers, session titles and locations may change. 

 

Separate pathways for Nutrition, Pharma and Bio will be offered as breakout sessions that run concurrently throughout the conference's three days.

 

All Conference Details

 

8 a.m.

Check-in

✦ Lobby

8:30-10 a.m.

Keynote

✦ Forum Hall

Join us for the opening keynote, "The Adversarial and Collaborative Facets of Regulatory Affairs: Opportunities and Challenges"

Carlos Gonzalez, Ph.D.

Hill's Pet Nutrition

10-10:15 a.m.

Break

10:15-11:30 a.m.

Session One Breakouts

11:45 a.m.-12:30 p.m.

Lunch

✦ Bistro

12:30-1:45

Session Two Breakouts

1:45-2 p.m.

Break

2:15-3:30 p.m.

Session Three Breakouts

3:15-3:45 p.m.

Break

3:30-4:15 p.m.

Speaker Panel and Day 1 Wrap-up

✦ Great Plains

5:30-7 p.m.

Networking Dinners | RSVPs Required

✦ Off-site

Join us for dinners hosted across various KC restaurants by subject matter experts. Choose which group to dine with on the RSVP form.
Session 1

"Navigating and Understanding AAFCO"

✦ Great Plains A

Time 10:15-11:30 a.m.

Dan King

Minnesota Department of Agriculture | AAFCO

Session 2A

"Regulatory Jenga: Navigating Import and Export Regulations in Animal Nutrition with the USDA"

✦ Great Plains A

Time 12:30-1:45 p.m.

Lyn Huffaker, D.V.M., Ph.D.

LH Solutions, USDA APHIS

Session 2B

"Animal Supplements and Legal Risk Considerations"

✦ Great Plains B

Time 12:30-1:45 p.m.
Get a clear look at how animal supplements are regulated and where the legal risks hide. Learn how to navigate product claims, stay compliant and avoid common pitfalls that can disrupt your business.

Bill Bookout

National Animal Supplement Council

Todd Harrison

Venable, LLP

Session 3A

"Import and Export of Nutrition Ingredients with the FDA"

✦ Great Plains A

Time 2:15-3:30p.m.
Join us for a practical look at FDA regulations for importing food and nutrition ingredients into the U.S. Learn what’s required at each step and who’s responsible along the way.

Tim Lombardo

EAS Consulting Group

Session 3B

TBA

✦ Great Plains B

Time 2:15-3:30p.m.
Session 1

TBA

✦ 221A

Time 10:15-11:30 a.m.
Session 2A

Panel: "NexGen Products"

✦ 221A

Time 12:30-1:45 p.m.

Matt Zehnder

PastureBio

Rob Hunter, Ph.D.

Moderator

Terrell Suddarth

Hilltop Bio

Session 2B

TBA

✦ 221B

Time 12:30-1:45 p.m.
Session 3A

Panel: "CRO Selection and Oversight"

✦ 221A

Time 2:15-3:30p.m.

Rob Hunter, Ph.D.

Moderator

Kyle Kappeler

Attentive Science

Dominic Warrino, Ph.D.

KCASBio

Session 3B

"Global Efforts: Changing Pharmacovigilance Landscape"

✦ 221B

Time 2:15-3:30p.m.

Martin Tiemann, D.V.M.

Boehringer Ingelheim

Session 1

TBA

✦ 222A

Time 10:15-11:30 a.m.
Session 2A

"Licensing New Products through CVB: Continuum of Studies Needed"

✦ 222A

Time 12:30-1:45 p.m.

Helen Smith

Kemin

Session 2B

TBA

✦ 222B

Time 12:30-1:45 p.m.
Session 3A

TBA

✦ 222A

Time 2:15-3:30p.m.
Session 3B

"Qualification and Validation of Equipment for FDA, USDA and Medical Devices"

✦ 222B

Time 2:15-3:30p.m.

Terrie Jo Hamtak

Merck Animal Health (retired)

8:30-9 a.m.

Research and Academic Breakfast

✦ Great Plains

Join us in Great Plains for a networking breakfast opportunity.
9-10:15 a.m.

Keynote

✦ Forum Hall

Keynote TBA
10:15-10:30 a.m.

Break

10:15-11:45 a.m.

Session One Breakouts

11:45 a.m.-12:30 p.m.

Lunch

✦ Bistro

Come to the Bistro and enjoy some lunch with K-State Olathe Student Services and Faculty.
12:30-2 p.m.

Professional Skills Workshop:
Communication and Appreciation in the Workplace

✦ Location TBA

Brent Mayabb, D.V.M., M.S.

Workshop Leader

2:30-2:45 p.m.

Break

2:45-3:30 p.m.

Day 2 Wrap-up

5:00-7 p.m.

Social After Hours

✦ Off-site

Details coming soon!
General Session

Panel: "Value of Interdisciplinary Approaches to Developing Nutrition Products"

✦ Great Plains A

Time 10:30-11:45 a.m.

Kathy Gross, Ph.D., PAS, Dip. ACAN

Moderator

Kelly Foos

Panelist

Amanda Anderson

Panelist

Haley Larson, Ph.D.

Panelist

General Session

"A Conversation on the Developing Technology of Monoclonal Antibodies"

✦ 221A

Time 10:30-11:45 a.m.

Jay Peterson

Elanco

Norm Brown, M.S.

Facilitator

General Session

"Career Opportunities in Animal Health"

✦ 222A

Time 10:30-11:45 a.m.

Paige Adams, D.V.M., Ph.D.

K-State Olathe

8:30-9:30 a.m.

Industry Resources Panel Breakfast

✦ Forum Hall

9:30-9:45

Break

9:45-11 a.m.

Session One Breakouts

11-11:15 a.m.

Break

11:15 a.m. -12:30 p.m.

Session Two Breakouts

12:30-1:30 p.m.

Lunch/Break

1:30-3 p.m.

Case Study Working Groups

3-3:30 p.m.

Closing Remarks and Day 3 Wrap Up

Session 1A

"Understanding Ingredient Approval Pathways"

✦ Great Plains A

Time 9:45-11 a.m.

Leah Wilkinson

AFIA

Session 1B

TBA

✦ Great Plains B

Time 9:45-11 a.m.
Session 2A

TBA

✦ Great Plains A

Time 11:15 a.m.-12:30 p.m.
Session 2B

TBA

✦ Great Plains B

Time 11:15 a.m.-12:30 p.m.
Case Study
Working Group A

"Elements of a Label: Livestock and Companion Animals"

✦ Great Plains A

Time 1:30-3 p.m.

Haley Larson, Ph.D.

K-State Olathe

Kathy Gross, Ph.D., PAS, Dip. ACAN

Kathy Gross, Ph.D., PAS, Dip. ACAN

Session 1

"Understanding ADUFA/AGDUFA Fees"

✦ 221A

Time 9:45-11 a.m.

Stephanie Batliner

Bimeda

Session 2A

"CMC Overview"

✦ 221A

Time 11:15 a.m.-12:30 p.m.

Stephanie Batliner

Bimeda

Session 2B

"Clinical Efficacy vs Study Claims"

✦ 221B

Time 11:15 a.m.-12:30 p.m.

Melinda Poole Cole, D.V.M.

Animal Clinical Investigation

Case Study
Working Group B

"Labeling and the FDA"

✦ 221A

Time 1:30-3 p.m.

Rob Hunter, Ph.D.

Animal Health Consultant

Jennifer Schofield, D.V.M., CPH

Elanco

Session 1A

"Navigating the Regulatory Pathways of Novel Oral Biologics: Scaling a Scientific Discovery into Manufacturing at Scale and Setting up Quality Control"

✦ 222A

Time 9:45-11 a.m.

Jolieke van Oosterwijk, Ph.D., M.S., MCB

US Biologic

Session 1B

"Leveraging Bioassays for Quality Control & Regulatory Considerations in Animal Health Biologics"

✦ 222B

Time 9:45-11 a.m.
Explore how emerging bioassays are improving quality control for animal vaccines, mAbs and mRNA therapeutics. This session covers practical tools for detecting impurities, validating potency and meeting today’s regulatory standards.

Maria Dashek, D.V.M., Ph.D., DACPV

Promega

Session 2A

"Innovation to Organization: From Compliance in a Post-licensure Setting"

✦ 222B

Time 11:15 a.m.-12:30 p.m.

John Brooke, Ph.D., MPH

US Biologic

Session 2B

TBA

✦ 222B

Time 11:15 a.m.-12:30 p.m.
Case Study
Working Group C

"Writing an Outline for Production (USDA)"

✦ 222A

Time 1:30-3 p.m.

Norm Brown, M.S.

Animal Health Consultant

Terrie Jo Hamtak

Merck Animal Health (retired)